Barclays’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Buy |
798,720
+352,837
| +79% | +$6.43M | ﹤0.01% | 948 |
|
|
2025
Q1 | $8.85M | Sell |
445,883
-95,210
| -18% | -$1.89M | ﹤0.01% | 1087 |
|
|
2024
Q4 | $9.28M | Buy |
541,093
+12,464
| +2% | +$214K | ﹤0.01% | 1171 |
|
|
2024
Q3 | $10.6M | Buy |
528,629
+347,692
| +192% | +$6.95M | ﹤0.01% | 1022 |
|
|
2024
Q2 | $2.02M | Sell |
180,937
-93,112
| -34% | -$1.04M | ﹤0.01% | 1695 |
|
|
2024
Q1 | $1.81M | Sell |
274,049
-306,689
| -53% | -$2.02M | ﹤0.01% | 2011 |
|
|
2023
Q4 | $2.63M | Buy |
580,738
+178,201
| +44% | +$805K | ﹤0.01% | 1968 |
|
|
2023
Q3 | $1.44M | Sell |
402,537
-10,544
| -3% | -$37.7K | ﹤0.01% | 1864 |
|
|
2023
Q2 | $1.52M | Sell |
413,081
-15,968
| -4% | -$58.9K | ﹤0.01% | 1913 |
|
|
2023
Q1 | $1.42M | Sell |
429,049
-35,718
| -8% | -$118K | ﹤0.01% | 1892 |
|
|
2022
Q4 | $1.8M | Sell |
464,767
-3,949
| -0.8% | -$15.3K | ﹤0.01% | 1701 |
|
|
2022
Q3 | $1.14M | Buy |
468,716
+356,293
| +317% | +$866K | ﹤0.01% | 2035 |
|
|
2022
Q2 | $222K | Sell |
112,423
-4,815
| -4% | -$9.51K | ﹤0.01% | 3070 |
|
|
2022
Q1 | $215K | Hold |
117,238
| – | – | ﹤0.01% | 3263 |
|
|
2021
Q4 | $165K | Sell |
117,238
-11,714
| -9% | -$16.5K | ﹤0.01% | 2878 |
|
|
2021
Q3 | $145K | Sell |
128,952
-328,795
| -72% | -$370K | ﹤0.01% | 3102 |
|
|
2021
Q2 | $733K | Buy |
457,747
+285,322
| +165% | +$457K | ﹤0.01% | 2275 |
|
|
2021
Q1 | $303K | Buy |
172,425
+172,339
| +200,394% | +$303K | ﹤0.01% | 2937 |
|
|
2020
Q4 | $0 | Sell |
86
-27,750
| -100% | – | ﹤0.01% | 3517 |
|
|
2020
Q3 | $66K | Sell |
27,836
-8,191
| -23% | -$19.4K | ﹤0.01% | 3177 |
|
|
2020
Q2 | $106K | Buy |
36,027
+12,727
| +55% | +$37.4K | ﹤0.01% | 3093 |
|
|
2020
Q1 | $67K | Sell |
23,300
-51,400
| -69% | -$148K | ﹤0.01% | 2972 |
|
|
2019
Q4 | $298K | Sell |
74,700
-353,887
| -83% | -$1.41M | ﹤0.01% | 2982 |
|
|
2019
Q3 | $1.91M | Buy |
428,587
+410,962
| +2,332% | +$1.83M | ﹤0.01% | 1801 |
|
|
2019
Q2 | $68K | Sell |
17,625
-37,842
| -68% | -$146K | ﹤0.01% | 3745 |
|
|
2019
Q1 | $211K | Buy |
55,467
+55,246
| +24,998% | +$210K | ﹤0.01% | 3008 |
|
|
2018
Q4 | $1K | Sell |
221
-7,031
| -97% | -$31.8K | ﹤0.01% | 3972 |
|
|
2018
Q3 | $45K | Buy |
7,252
+5,864
| +422% | +$36.4K | ﹤0.01% | 3764 |
|
|
2018
Q2 | $6K | Sell |
1,388
-1,513
| -52% | -$6.54K | ﹤0.01% | 3977 |
|
|
2018
Q1 | $13K | Buy |
+2,901
| New | +$13K | ﹤0.01% | 3908 |
|